Sunday, November 9, 2025
HomeFINANCE NEWSVertex Pharmaceuticals Incorporated (VRTX) Discusses Updated Data for Pove in IgAN and...

Vertex Pharmaceuticals Incorporated (VRTX) Discusses Updated Data for Pove in IgAN and pMN and Developments in Kidney Disease Portfolio – Slideshow


Q3: 2025-11-03 Earnings Summary

EPS of $4.80 beats by $0.22

 | Revenue of $3.08B (10.99% Y/Y) beats by $17.21M

This article was written by

Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts Team



Source link

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments